ILLUMINA, INC.

ILMN
Delayed Quote. Delayed  - 09/25 04:00:00 pm
299.89USD +4.74%
Prev.286.3100
Open284.4300
High302.2300
Low279.8800
Volume4 336 929
Latest news
4h ago
2d ago
4d ago
4d ago
Chart ILLUMINA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance315401384
Spread/Res.-4,8%-25%-22%
Spread/Supp.12%17%29%
Support269256233
Financials
Sales 2020 3 090 M - -
Net income 2020 528 M - -
Net cash 2020 2 294 M - -
P/E ratio 2020 87,2x
Yield 2020 -
Capitalization 43 892 M 43 892 M -
EV / Sales 2020 13,5x
EV / Sales 2021 10,4x
Nbr of Employees 7 700
Free-Float 75,1%
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations,...

>> Read more
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2020-10-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 17
Average target price 306,31 $
Last Close Price 299,89 $
Spread / Highest target 30,0%
Spread / Average Target 2,14%
Spread / Lowest Target -26,6%